Capital Investment Counsel Inc’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$362K Hold
4,625
0.05% 141
2025
Q1
$335K Sell
4,625
-500
-10% -$36.2K 0.05% 144
2024
Q4
$379K Sell
5,125
-300
-6% -$22.2K 0.06% 130
2024
Q3
$358K Hold
5,425
0.05% 140
2024
Q2
$501K Sell
5,425
-920
-14% -$85K 0.08% 111
2024
Q1
$606K Buy
6,345
+100
+2% +$9.56K 0.1% 98
2023
Q4
$476K Sell
6,245
-100
-2% -$7.63K 0.08% 113
2023
Q3
$440K Sell
6,345
-680
-10% -$47.1K 0.09% 110
2023
Q2
$663K Hold
7,025
0.13% 93
2023
Q1
$581K Sell
7,025
-400
-5% -$33.1K 0.13% 98
2022
Q4
$554K Buy
7,425
+4,905
+195% +$366K 0.13% 99
2022
Q3
$208K Buy
2,520
+40
+2% +$3.3K 0.06% 141
2022
Q2
$236K Hold
2,480
0.06% 148
2022
Q1
$292K Hold
2,480
0.06% 145
2021
Q4
$321K Buy
+2,480
New +$321K 0.06% 143
2021
Q3
Sell
-2,480
Closed -$257K 193
2021
Q2
$257K Buy
2,480
+80
+3% +$8.29K 0.06% 142
2021
Q1
$201K Sell
2,400
-1,200
-33% -$101K 0.05% 158
2020
Q4
$328K Hold
3,600
0.1% 106
2020
Q3
$287K Hold
3,600
0.08% 115
2020
Q2
$249K Hold
3,600
0.1% 115
2020
Q1
$226K Sell
3,600
-675
-16% -$42.4K 0.09% 118
2019
Q4
$332K Sell
4,275
-300
-7% -$23.3K 0.11% 112
2019
Q3
$335K Hold
4,575
0.12% 109
2019
Q2
$282K Hold
4,575
0.1% 121
2019
Q1
$292K Hold
4,575
0.11% 122
2018
Q4
$234K Hold
4,575
0.1% 121
2018
Q3
$266K Buy
4,575
+225
+5% +$13.1K 0.1% 119
2018
Q2
$211K Buy
+4,350
New +$211K 0.08% 135